Sharon Hassin-Baer
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Sharon Hassin-Baer has a total of 346 co-authors. Here are the top co-authors by number of shared publications:
Oren S. Cohen
Affiliations Sackler Faculty of Medicine, Tel-Aviv University, Tel-Aviv, Israel, Department of Neurology, Assaf Harofeh Medical Center, Zerifin, Israel
10 shared publications- Roy N. Alcalay
Department of Neurology, Columbia University Irving Medical Center
6 shared publications - Ziv Gan-Or
Department of Human Genetics, McGill University, Montreal, QC, Canada
6 shared publications - Eric Yu
The Neuro (Montreal Neurological Institute-Hospital), McGill University, Montreal, Quebec, Canada
5 shared publications - Nicolas Dupré
CHU de Québec–Université Laval, Université Laval
5 shared publications - Simon Israeli-Korn
Movement Disorders Institute, Department of Neurology, Chaim Sheba Medical Center, Ramat Gan, Israel
5 shared publications
Latest Publications
- Open Access
- 23 July 2026
- Published by Springer Nature in Fluids and Barriers of the CNS
- Vol. 23 (1)
Motor network neurophysiological (TMS-EEG) markers as predictors of outcomes of ventriculoperitoneal shunt sustained for over a year in normal pressure hydrocephalus
Current practice for normal pressure hydrocephalus (NPH) relies on clinical presentation, imaging, and various clinical procedures to determine the need fo
- 23 July 2026
- Published by Springer Nature in Fluids and Barriers of the CNS
- Vol. 23 (1)
Open AccessMotor network neurophysiological (TMS-EEG) markers as predictors of outcomes of ventriculoperitoneal shunt sustained for over a year in normal pressure hydrocephalus
Current practice for normal pressure hydrocephalus (NPH) relies on clinical presentation, imaging, and various clinical procedures to determine the need fo
- 20 October 2025
- Published by Springer Nature
- p. 217-223
Lessons Taken from the Israeli Cerebrotendinous Xanthomatosis (CTX) Cohort: Can We Improve Outcomes?
- 20 October 2025
- Published by Springer Nature
- p. 217-223
Lessons Taken from the Israeli Cerebrotendinous Xanthomatosis (CTX) Cohort: Can We Improve Outcomes?
- Open Access
- 6 March 2025
- Published by Springer Nature in Journal of NeuroEngineering and Rehabilitation
- Vol. 22 (1) , 1-13
Submovements in manual tracking: people with Parkinson’s disease produce more submovements than age-matched controls
Background: In general, people are unable to produce slow, smooth movements - as movements become slower (i.e., with longer durations), they become jerkier. A hallmark feature of Parkinson’s disease is bradykinesia - slowness of movement. In this study, we investigate the intersection of these two observations - how do people with Parkinson’s disease (PwP) perform in a slow tracking task, and how does it vary as a function of movement frequency? On the one hand, as PwP move more slowly in day-to-day life, they may be better in a slow tracking task. On the other hand, their general impairment in movement production may lead to worse tracking outcomes. Methods: We used a well-tested tracking task known as the one-person mirror game, where participants control the left-right movement of an ellipse on a graphics tablet. They did so using a stylus and were instructed to match the horizontal location of a stimulus, an ellipse moving in a sinusoidal fashion at different movement frequencies and peak velocities. We calculated the submovement rate, identifying both type 2 (acceleration zero crossings) and type 3 (jerk zero crossings) from the trajectories, as well as relative position error (dX) and mean timing error (dT). To account for age-related performance decline, we tested three groups: PwP (N = 31), age-matched controls (OC; N = 29), and younger controls (YC; N = 30) in a cross-sectional study, and used mixed-design ANOVAs to compare across groups and movement frequencies. Results: We reproduced earlier results showing that slow movements (i.e., with lower frequencies) require more submovements to track. PwP also generally performed more submovements than the other two groups, but only for type 3 submovements, whereas OC and YC performed submovements at a similar rate. Younger controls (YC) performed fewer tracking errors than older participants (both PwP and OC), and OC performed better than PwP. Conclusions: The ability to smoothly track showed an age-related decline, with PwP producing more errors and using more submovements. This may be due to reduced automaticity in movement production. The findings of the study can be used to guide optimal movement frequencies for motor training for older adults and PwP.
- 6 March 2025
- Published by Springer Nature in Journal of NeuroEngineering and Rehabilitation
- Vol. 22 (1) , 1-13
Open AccessSubmovements in manual tracking: people with Parkinson’s disease produce more submovements than age-matched controls
Background: In general, people are unable to produce slow, smooth movements - as movements become slower (i.e., with longer durations), they become jerkier. A hallmark feature of Parkinson’s disease is bradykinesia - slowness of movement. In this study, we investigate the intersection of these two observations - how do people with Parkinson’s disease (PwP) perform in a slow tracking task, and how does it vary as a function of movement frequency? On the one hand, as PwP move more slowly in day-to-day life, they may be better in a slow tracking task. On the other hand, their general impairment in movement production may lead to worse tracking outcomes. Methods: We used a well-tested tracking task known as the one-person mirror game, where participants control the left-right movement of an ellipse on a graphics tablet. They did so using a stylus and were instructed to match the horizontal location of a stimulus, an ellipse moving in a sinusoidal fashion at different movement frequencies and peak velocities. We calculated the submovement rate, identifying both type 2 (acceleration zero crossings) and type 3 (jerk zero crossings) from the trajectories, as well as relative position error (dX) and mean timing error (dT). To account for age-related performance decline, we tested three groups: PwP (N = 31), age-matched controls (OC; N = 29), and younger controls (YC; N = 30) in a cross-sectional study, and used mixed-design ANOVAs to compare across groups and movement frequencies. Results: We reproduced earlier results showing that slow movements (i.e., with lower frequencies) require more submovements to track. PwP also generally performed more submovements than the other two groups, but only for type 3 submovements, whereas OC and YC performed submovements at a similar rate. Younger controls (YC) performed fewer tracking errors than older participants (both PwP and OC), and OC performed better than PwP. Conclusions: The ability to smoothly track showed an age-related decline, with PwP producing more errors and using more submovements. This may be due to reduced automaticity in movement production. The findings of the study can be used to guide optimal movement frequencies for motor training for older adults and PwP.
- 22 November 2024
- Published by Elsevier in Parkinsonism & Related Disorders
- Vol. 130, 107217
TMS-evoked potentials provide novel neurophysiological features of Tourette syndrome
- 22 November 2024
- Published by Elsevier in Parkinsonism & Related Disorders
- Vol. 130, 107217
TMS-evoked potentials provide novel neurophysiological features of Tourette syndrome
- Open Access
- 28 June 2024
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 25 (13) , 7102
GBA1-Associated Parkinson’s Disease Is a Distinct Entity
GBA1-associated Parkinson’s disease (GBA1-PD) is increasingly recognized as a distinct entity within the spectrum of parkinsonian disorders. This review explores the unique pathophysiological features, clinical progression, and genetic underpinnings that differentiate GBA1-PD from idiopathic Parkinson’s disease (iPD). GBA1-PD typically presents with earlier onset and more rapid progression, with a poor response to standard PD medications. It is marked by pronounced cognitive impairment and a higher burden of non-motor symptoms compared to iPD. Additionally, patients with GBA1-PD often exhibit a broader distribution of Lewy bodies within the brain, accentuating neurodegenerative processes. The pathogenesis of GBA1-PD is closely associated with mutations in the GBA1 gene, which encodes the lysosomal enzyme beta-glucocerebrosidase (GCase). In this review, we discuss two mechanisms by which GBA1 mutations contribute to disease development: ‘haploinsufficiency,’ where a single functional gene copy fails to produce a sufficient amount of GCase, and ‘gain of function,’ where the mutated GCase acquires harmful properties that directly impact cellular mechanisms for alpha-synuclein degradation, leading to alpha-synuclein aggregation and neuronal cell damage. Continued research is advancing our understanding of how these mechanisms contribute to the development and progression of GBA1-PD, with the ‘gain of function’ mechanism appearing to be the most plausible. This review also explores the implications of GBA1 mutations for therapeutic strategies, highlighting the need for early diagnosis and targeted interventions. Currently, small molecular chaperones have shown the most promising clinical results compared to other agents. This synthesis of clinical, pathological, and molecular aspects underscores the assertion that GBA1-PD is a distinct clinical and pathobiological PD phenotype, necessitating specific management and research approaches to better understand and treat this debilitating condition.
- 28 June 2024
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 25 (13) , 7102
Open AccessGBA1-Associated Parkinson’s Disease Is a Distinct Entity
GBA1-associated Parkinson’s disease (GBA1-PD) is increasingly recognized as a distinct entity within the spectrum of parkinsonian disorders. This review explores the unique pathophysiological features, clinical progression, and genetic underpinnings that differentiate GBA1-PD from idiopathic Parkinson’s disease (iPD). GBA1-PD typically presents with earlier onset and more rapid progression, with a poor response to standard PD medications. It is marked by pronounced cognitive impairment and a higher burden of non-motor symptoms compared to iPD. Additionally, patients with GBA1-PD often exhibit a broader distribution of Lewy bodies within the brain, accentuating neurodegenerative processes. The pathogenesis of GBA1-PD is closely associated with mutations in the GBA1 gene, which encodes the lysosomal enzyme beta-glucocerebrosidase (GCase). In this review, we discuss two mechanisms by which GBA1 mutations contribute to disease development: ‘haploinsufficiency,’ where a single functional gene copy fails to produce a sufficient amount of GCase, and ‘gain of function,’ where the mutated GCase acquires harmful properties that directly impact cellular mechanisms for alpha-synuclein degradation, leading to alpha-synuclein aggregation and neuronal cell damage. Continued research is advancing our understanding of how these mechanisms contribute to the development and progression of GBA1-PD, with the ‘gain of function’ mechanism appearing to be the most plausible. This review also explores the implications of GBA1 mutations for therapeutic strategies, highlighting the need for early diagnosis and targeted interventions. Currently, small molecular chaperones have shown the most promising clinical results compared to other agents. This synthesis of clinical, pathological, and molecular aspects underscores the assertion that GBA1-PD is a distinct clinical and pathobiological PD phenotype, necessitating specific management and research approaches to better understand and treat this debilitating condition.
- Open Access
Quantifying Changes in Dexterity as a Result of Piano Training in People with Parkinson’s Disease
People with Parkinson’s disease often show deficits in dexterity, which, in turn, can lead to limitations in performing activities of daily life. Previous studies have suggested that training in playing the piano may improve or prevent a decline in dexterity in this population. In this pilot study, we tested three participants on a six-week, custom, piano-based training protocol, and quantified dexterity before and after the intervention using a sensor-enabled version of the nine-hole peg test, the box and block test, a test of finger synergies using unidimensional force sensors, and the Quantitative Digitography test using a digital piano, as well as selected relevant items from the motor parts of the MDS-Unified Parkinson’s Disease Rating Scale (MDS-UPDRS) and the Parkinson’s Disease Questionnaire (PDQ-39) quality of life questionnaire. The participants showed improved dexterity following the training program in several of the measures used. This pilot study proposes measures that can track changes in dexterity as a result of practice in people with Parkinson’s disease and describes a potential protocol that needs to be tested in a larger cohort.
Open AccessQuantifying Changes in Dexterity as a Result of Piano Training in People with Parkinson’s Disease
People with Parkinson’s disease often show deficits in dexterity, which, in turn, can lead to limitations in performing activities of daily life. Previous studies have suggested that training in playing the piano may improve or prevent a decline in dexterity in this population. In this pilot study, we tested three participants on a six-week, custom, piano-based training protocol, and quantified dexterity before and after the intervention using a sensor-enabled version of the nine-hole peg test, the box and block test, a test of finger synergies using unidimensional force sensors, and the Quantitative Digitography test using a digital piano, as well as selected relevant items from the motor parts of the MDS-Unified Parkinson’s Disease Rating Scale (MDS-UPDRS) and the Parkinson’s Disease Questionnaire (PDQ-39) quality of life questionnaire. The participants showed improved dexterity following the training program in several of the measures used. This pilot study proposes measures that can track changes in dexterity as a result of practice in people with Parkinson’s disease and describes a potential protocol that needs to be tested in a larger cohort.
- Open Access
- 2 January 2024
- Published by Springer Nature in Scientific Reports
- Vol. 14 (1) , 1-17
Home-based monitoring of persons with advanced Parkinson’s disease using smartwatch-smartphone technology
Movement deterioration is the hallmark of Parkinson’s disease (PD), characterized by levodopa-induced motor-fluctuations (i.e., symptoms’ variability related to the medication cycle) in advanced stages. However, motor symptoms are typically too sporadically and/or subjectively assessed, ultimately preventing the effective monitoring of their progression, and thus leading to suboptimal treatment/therapeutic choices. Smartwatches (SW) enable a quantitative-oriented approach to motor-symptoms evaluation, namely home-based monitoring (HBM) using an embedded inertial measurement unit. Studies validated such approach against in-clinic evaluations. In this work, we aimed at delineating personalized motor-fluctuations’ profiles, thus capturing individual differences. 21 advanced PD patients with motor fluctuations were monitored for 2 weeks using a SW and a smartphone-dedicated app (Intel Pharma Analytics Platform). The SW continuously collected passive data (tremor, dyskinesia, level of activity using dedicated algorithms) and active data, i.e., time-up-and-go, finger tapping, hand tremor and hand rotation carried out daily, once in OFF and once in ON levodopa periods. We observed overall high compliance with the protocol. Furthermore, we observed striking differences among the individual patterns of symptoms’ levodopa-related variations across the HBM, allowing to divide our participants among four data-driven, motor-fluctuations’ profiles. This highlights the potential of HBM using SW technology for revolutionizing clinical practices.
- 2 January 2024
- Published by Springer Nature in Scientific Reports
- Vol. 14 (1) , 1-17
Open AccessHome-based monitoring of persons with advanced Parkinson’s disease using smartwatch-smartphone technology
Movement deterioration is the hallmark of Parkinson’s disease (PD), characterized by levodopa-induced motor-fluctuations (i.e., symptoms’ variability related to the medication cycle) in advanced stages. However, motor symptoms are typically too sporadically and/or subjectively assessed, ultimately preventing the effective monitoring of their progression, and thus leading to suboptimal treatment/therapeutic choices. Smartwatches (SW) enable a quantitative-oriented approach to motor-symptoms evaluation, namely home-based monitoring (HBM) using an embedded inertial measurement unit. Studies validated such approach against in-clinic evaluations. In this work, we aimed at delineating personalized motor-fluctuations’ profiles, thus capturing individual differences. 21 advanced PD patients with motor fluctuations were monitored for 2 weeks using a SW and a smartphone-dedicated app (Intel Pharma Analytics Platform). The SW continuously collected passive data (tremor, dyskinesia, level of activity using dedicated algorithms) and active data, i.e., time-up-and-go, finger tapping, hand tremor and hand rotation carried out daily, once in OFF and once in ON levodopa periods. We observed overall high compliance with the protocol. Furthermore, we observed striking differences among the individual patterns of symptoms’ levodopa-related variations across the HBM, allowing to divide our participants among four data-driven, motor-fluctuations’ profiles. This highlights the potential of HBM using SW technology for revolutionizing clinical practices.
- 2 September 2023
- Published by Springer Nature in neurogenetics
- Vol. 24 (4) , 303-310
Adult-onset Alexander disease among patients of Jewish Syrian descent
Alexander disease (AxD) is a rare autosomal dominant leukodystrophy caused by heterozygous mutations in the glial fibrillary acid protein (GFAP) gene. The age of symptoms onset ranges from infancy to adulthood, with variable clinical and radiological manifestations. Adult-onset AxD manifests as a chronic and progressive condition, characterized by bulbar, motor, cerebellar, and other clinical signs and symptoms. Neuroradiological findings typically involve the brainstem and cervical spinal cord. Adult-onset AxD has been described in diverse populations but is rare in Israel. We present a series of patients diagnosed with adult-onset AxD from three families, all of Jewish Syrian descent. Five patients (4 females) were diagnosed with adult-onset AxD due to the heterozygous mutation c.219G > A, p.Met73Ile in GFAP. Age at symptoms onset ranged from 48 to 61 years. Clinical characteristics were typical and involved progressive bulbar and gait disturbance, followed by pyramidal and cerebellar impairment, dysautonomia, and cognitive decline. Imaging findings included medullary and cervical spinal atrophy and mostly infratentorial white matter hyperintensities. A newly recognized cluster of adult-onset AxD in Jews of Syrian origin is presented. This disorder should be considered in differential diagnosis in appropriate circumstances. Genetic counselling for family members is required in order to discuss options for future family planning.
- 2 September 2023
- Published by Springer Nature in neurogenetics
- Vol. 24 (4) , 303-310
Adult-onset Alexander disease among patients of Jewish Syrian descent
Alexander disease (AxD) is a rare autosomal dominant leukodystrophy caused by heterozygous mutations in the glial fibrillary acid protein (GFAP) gene. The age of symptoms onset ranges from infancy to adulthood, with variable clinical and radiological manifestations. Adult-onset AxD manifests as a chronic and progressive condition, characterized by bulbar, motor, cerebellar, and other clinical signs and symptoms. Neuroradiological findings typically involve the brainstem and cervical spinal cord. Adult-onset AxD has been described in diverse populations but is rare in Israel. We present a series of patients diagnosed with adult-onset AxD from three families, all of Jewish Syrian descent. Five patients (4 females) were diagnosed with adult-onset AxD due to the heterozygous mutation c.219G > A, p.Met73Ile in GFAP. Age at symptoms onset ranged from 48 to 61 years. Clinical characteristics were typical and involved progressive bulbar and gait disturbance, followed by pyramidal and cerebellar impairment, dysautonomia, and cognitive decline. Imaging findings included medullary and cervical spinal atrophy and mostly infratentorial white matter hyperintensities. A newly recognized cluster of adult-onset AxD in Jews of Syrian origin is presented. This disorder should be considered in differential diagnosis in appropriate circumstances. Genetic counselling for family members is required in order to discuss options for future family planning.
- Open Access
- 26 July 2023
- Published by Springer Nature in BMC Neurology
- Vol. 23 (1) , 1-9
Differential gait adaptation patterns in Parkinson’s disease – a split belt treadmill pilot study
Background: Interventions using split belt treadmills (SBTM) aim to improve gait symmetry (GA) in Parkinson's disease (PD). Comparative effects in conjugated SBTM conditions were not studied systematically despite potentially affecting intervention outcomes. We compared gait adaptation effects instigated by SBTM walking with respect to the type (increased\decreased speed) and the side (more/less affected) of the manipulated belt in PD. Methods: Eight individuals with PD performed four trials of SBTM walking, each consisted of baseline tied belt configuration, followed by split belt setting – either WS or BS belt's speed increased or decreased by 50% from baseline, and final tied belt configuration. Based on the disease's motor symptoms, a 'worst' side (WS) and a 'best' side (BS) were defined for each participant. Results: SB initial change in GA was significant regardless of condition (p ≤ 0.02). This change was however more pronounced for BS-decrease compared with its matching condition WS-increase (p = 0.016). Similarly, the same was observed for WS-decrease compared to BS-increase (p = 0.013). Upon returning to tied belt condition, both BS-decrease and WS-increased resulted in a significant change in GA (p = 0.04). Upper limb asymmetry followed a similar trend of GA reversal, although non-significant. Conclusions: Stronger effects on GA were obtained by decreasing the BS belt’s speed of the best side, rather than increasing the speed of the worst side. Albeit a small sample size, which limits the generalisability of these results, we propose that future clinical studies would benefit from considering such methodological planning of SBTM intervention, for maximising of intervention outcomes. Larger samples may reveal arm swinging asymmetries alterations to match SBTM adaptation patterns. Finally, further research is warranted to study post-adaption effects in order to define optimal adaptation schemes to maximise the therapeutic effect of SBTM based interventions.
- 26 July 2023
- Published by Springer Nature in BMC Neurology
- Vol. 23 (1) , 1-9
Open AccessDifferential gait adaptation patterns in Parkinson’s disease – a split belt treadmill pilot study
Background: Interventions using split belt treadmills (SBTM) aim to improve gait symmetry (GA) in Parkinson's disease (PD). Comparative effects in conjugated SBTM conditions were not studied systematically despite potentially affecting intervention outcomes. We compared gait adaptation effects instigated by SBTM walking with respect to the type (increased\decreased speed) and the side (more/less affected) of the manipulated belt in PD. Methods: Eight individuals with PD performed four trials of SBTM walking, each consisted of baseline tied belt configuration, followed by split belt setting – either WS or BS belt's speed increased or decreased by 50% from baseline, and final tied belt configuration. Based on the disease's motor symptoms, a 'worst' side (WS) and a 'best' side (BS) were defined for each participant. Results: SB initial change in GA was significant regardless of condition (p ≤ 0.02). This change was however more pronounced for BS-decrease compared with its matching condition WS-increase (p = 0.016). Similarly, the same was observed for WS-decrease compared to BS-increase (p = 0.013). Upon returning to tied belt condition, both BS-decrease and WS-increased resulted in a significant change in GA (p = 0.04). Upper limb asymmetry followed a similar trend of GA reversal, although non-significant. Conclusions: Stronger effects on GA were obtained by decreasing the BS belt’s speed of the best side, rather than increasing the speed of the worst side. Albeit a small sample size, which limits the generalisability of these results, we propose that future clinical studies would benefit from considering such methodological planning of SBTM intervention, for maximising of intervention outcomes. Larger samples may reveal arm swinging asymmetries alterations to match SBTM adaptation patterns. Finally, further research is warranted to study post-adaption effects in order to define optimal adaptation schemes to maximise the therapeutic effect of SBTM based interventions.